OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
1286
Results
Show all
Save search
Copy query
Show results for
Unknown
(1190)
Proteomics
(58)
Transcriptomics
(15)
Metabolomics
(14)
Genomics
(9)
Organisms
Homo sapiens
(49)
Mus musculus
(9)
Arabidopsis thaliana
(4)
Triticum aestivum
(3)
Rattus norvegicus
(2)
Plutella xylostella
(1)
Aerodramus hirundinaceus
(1)
Aspergillus flavus NRRL3357
(1)
Danio rerio
(1)
Escherichia coli RS218
(1)
Haloferax volcanii
(1)
Nostoc sp. PCC 7120 = FACHB-418
(1)
Oryctolagus cuniculus
(1)
Oryza sativa
(1)
Bacteroides thetaiotaomicron VPI-5482
(1)
Rudbeckia hirta
(1)
Tagetes erecta
(1)
Toxoplasma gondii
(1)
Zea mays
(1)
Repository
iProX
(35)
pride
(19)
biostudies-arrayexpress
(17)
MetaboLights
(14)
EGA
(7)
MassIVE
(3)
jPOST
(1)
Tissue
Cell culture
(6)
Leaf
(3)
Plant cell
(3)
Embryonic stem cell
(2)
Hepatocyte
(2)
Kidney
(2)
Liver
(2)
Blood plasma
(1)
Blood serum
(1)
Brain
(1)
Epithelial cell
(1)
Flower
(1)
Heart
(1)
Intestine
(1)
Lung
(1)
Neutrophil
(1)
Permanent cell line cell
(1)
Root
(1)
Spleen
(1)
Disease
Breast cancer
(1)
Cerebrovascular disease
(1)
Disease free
(1)
Liver cancer
(1)
Lymphoma
(1)
Technology Type
Mass Spectrometry
(19)
Mass spectrometry
(11)
Shotgun proteomics
(7)
Data-dependent acquisition
(4)
Mass spectrometry assay
(3)
Affinity purification coupled with mass spectrometry proteomics
(2)
Bottom-up proteomics
(2)
Gel-based experiment
(2)
Illumina Genome Analyzer II, Illumina HiSeq 2000
(1)
Illumina HiSeq 2000
(1)
Data-independent acquisition
(1)
Mass spectrometry imaging
(1)
Proteogenomics
(1)
Instrument Platform
Liquid Chromatography MS - positive - reverse phase
(8)
Liquid Chromatography MS - negative - reverse phase
(7)
Liquid Chromatography MS - positive - hilic
(3)
Orbitrap Fusion Lumos
(2)
Liquid Chromatography MS - negative - hilic
(2)
LTQ Orbitrap Velos
(1)
Q Exactive
(1)
Direct infusion MS - negative
(1)
Gas Chromatography MS - positive
(1)
Liquid Chromatography MS - Negative (LC-MS (Negative))
(1)
Liquid Chromatography MS - Positive (LC-MS (Positive))
(1)
Liquid Chromatography MS - alternating - hilic
(1)
Liquid Chromatography MS - alternating - reverse phase
(1)
Liquid Chromatography MS - alternating – hilic
(1)
Publication Date
2022
(16)
2023
(14)
2025
(11)
2024
(9)
2014
(7)
2026
(7)
2021
(6)
2010
(5)
2020
(3)
2019
(3)
2012
(2)
2011
(2)
2016
(1)
2013
(1)
2018
(1)
2017
(1)
CHEBI ID
CHEBI:17596
(9)
CHEBI:16015
(7)
CHEBI:16393
(7)
CHEBI:16704
(7)
CHEBI:16737
(7)
CHEBI:16919
(7)
CHEBI:17368
(7)
CHEBI:17750
(7)
CHEBI:17895
(7)
CHEBI:24813
(7)
CHEBI:15724
(6)
CHEBI:15891
(6)
CHEBI:15971
(6)
CHEBI:16335
(6)
CHEBI:16414
(6)
CHEBI:16750
(6)
CHEBI:16828
(6)
CHEBI:17015
(6)
CHEBI:17154
(6)
CHEBI:17203
(6)
CHEBI:17295
(6)
CHEBI:17351
(6)
CHEBI:17405
(6)
CHEBI:17509
(6)
CHEBI:17650
(6)
CHEBI:17786
(6)
CHEBI:18019
(6)
CHEBI:18050
(6)
CHEBI:18183
(6)
CHEBI:18347
(6)
Metabolite Name
Inosine
(5)
Hypoxanthine
(4)
L-Alanine
(4)
L-Tyrosine
(4)
Taurine
(4)
Xanthine
(4)
Creatine
(3)
Creatinine
(3)
Genistein
(3)
Glutathione
(3)
Guanine
(3)
L-Leucine
(3)
L-histidine
(3)
L-lysine
(3)
L-norleucine
(3)
L-proline
(3)
Melatonin
(3)
Pyrrole-2-carboxylic acid
(3)
Taurocholic acid
(3)
Testosterone
(3)
Uridine
(3)
1-methyladenosine
(2)
2'-O-methylguanosine
(2)
3-methoxytyramine
(2)
5-Hydroxyindoleacetate
(2)
5-Hydroxyindoleacetic acid
(2)
5-Hydroxymethyluracil
(2)
5-methylcytidine
(2)
Acetylcarnitine
(2)
Acetylcholine
(2)
Study type
Transcription profiling by array
(9)
ChIP-chip by tiling array
(2)
ChIP-seq
(2)
RNA-seq of coding RNA
(2)
Genotyping by array
(1)
Other
(1)
Release Date
2025
(207)
2022
(175)
2024
(170)
2023
(154)
2021
(123)
2020
(72)
2019
(61)
2018
(48)
2016
(33)
2017
(33)
2015
(33)
2014
(26)
2026
(26)
2013
(15)
2012
(9)
2011
(8)
2010
(7)
2008
(4)
2006
(2)
2007
(1)
Lab affiliation
Agronomy College, Henan Agricultural University, China
(2)
Nankai University
(2)
1Department of Pathology, Dana-Farber/Harvard Cancer Center, PhD Program in Immunology, Harvard Medical School; Department of Laboratory Medicine, Boston Children's Hospital, Enders Research Building, Room 811, Boston, MA, 02115, USA
(1)
Agronomy College/National Key Laboratory of Wheat and Corn Crop/Collaborative Innovation Center of Henan Grain Crops, Henan Agricultural University ,Zhengzhou China
(1)
Department of Parasitology, School of Basic Medical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, China
(1)
Departments of Critical Care Medicine, the First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, 150001, China.
(1)
Huazhong University of Science and Technology
(1)
Institute of Biomedical Engineering and Technology, Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development, School of Chemistry and Molecular Engineering, East China Normal University, Shanghai 200062, P.R. China
(1)
Lanzhou University, Lanzhou, Gansu Province, China
(1)
National Key Laboratory of Crop Genetic Improvement Huazhong Agricultural University Wuhan 430070, China
(1)
Ocean University of China
(1)
School of Health Preservation and Rehabilitation, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
(1)
State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou 510060, China
(1)
State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences Beijing, Beijing Institute of Lifeomics, Beijing 102206, China
(1)
Team: Mass spectrometry of biological molecules Institute CBMN for Chemistry and Biology of Membranes and Nano-objects UMR 5248 CNRS-Bordeaux University 33607 Pessac - FRANCE
(1)
Zhejiang University
(1)
Zhengzhou University
(1)
Previous
page
1 / 129
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
129
Next
page
Sort
by:
Relevance
Page size
10
A network pharmacology-based approach to analyse potential targets of traditional herbal formulas: An example of Yu Ping Feng decoction.
Not available
S-EPMC6065326
|
biostudies-literature
Cite
Yu-Ping-Feng-San improve the immunosuppression of microenvironment in hepatocellular carcinoma by promoting the maturation of DCs through the JAK2-STAT3 pathway.
Not available
S-EPMC11682348
|
biostudies-literature
Cite
MiR-9a-5p regulates proliferation and migration of hepatic stellate cells under pressure through inhibition of Sirt1.
Not available
S-EPMC4566383
|
biostudies-literature
Cite
Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and gastric cancer susceptibility.
Not available
S-EPMC4145786
|
biostudies-literature
Cite
Tail domains of myosin-1e regulate phosphatidylinositol signaling and F-actin polymerization at the ventral layer of podosomes.
Not available
S-EPMC6589698
|
biostudies-literature
Cite
Intermittent F-actin Perturbations by Magnetic Fields Inhibit Breast Cancer Metastasis.
Not available
S-EPMC10017101
|
biostudies-literature
Cite
Soluble CD83 Regulates Dendritic Cell-T Cell Immunological Synapse Formation by Disrupting Rab1a-Mediated F-Actin Rearrangement.
Not available
S-EPMC7874230
|
biostudies-literature
Cite
GhCDPK60 positively regulates drought stress tolerance in both transgenic
Arabidopsis
and cotton by regulating proline content and ROS level.
Not available
S-EPMC9751749
|
biostudies-literature
Cite
Insights into the Genomic Regions and Candidate Genes of Senescence-Related Traits in Upland Cotton via GWAS.
Not available
S-EPMC9368895
|
biostudies-literature
Cite
Comparison of machine learning models and CEUS LI-RADS in differentiation of hepatic carcinoma and liver metastases in patients at risk of both hepatitis and extrahepatic malignancy.
Not available
S-EPMC10278254
|
biostudies-literature
Cite
Previous
page
1 / 129
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
129
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets